Bioretec Ltd Company announcement 13 February 2025 at 9:30 a.m.
TAMPERE, Finland, Feb. 13, 2026 /PRNewswire/ — This company announcement is a summary of Bioretec Ltd’s financial statements bulletin for January–December 2025. The complete financial statements bulletin with tables is attached to this release as a pdf file and available at the company’s web pages at https://investors.bioretec.com/en/reports_and_presentations The financial statements bulletin is unaudited.
July–December 2025 in brief
- Net sales amounted to EUR 1,448 thousand (6–12/2024: EUR 2,482 thousand)
- Sales margin was EUR 1,006 (1,770) thousand, or 69.5% (71.3%) of net sales
- EBITDA was EUR -3,919 (-2,189) thousand
- The result for the reporting period amounted to EUR -3,855 (-2,730) thousand
- On December 16, Bioretec updated its strategy for 2026–2028 and provided new financial targets for the strategy period
January–December 2025 in brief
- Net sales amounted to EUR 3,522 thousand (1–12/2024: EUR 4,544 thousand)
- Sales margin was EUR 2,314 (3,221) thousand, or 65.7% (70.9%) of net sales
- EBITDA was EUR -8,476 (-4,053) thousand
- The result for the reporting period amounted to EUR -9,483 (-4,614) thousand
- The Board of Directors proposes that no dividend be distributed for the financial period January 1 – December 31, 2025
Key figures
|
EUR 1,000 unless otherwise indicated |
7–12/2025 |
7–12/2024 |
Change, % |
1–12/2025 |
1–12/2024 |
Change, % |
|
Net sales |
1,448 |
2,482 |
-41.7 % |
3,522 |
4,544 |
-22.5 % |
|
Sales margin |
1,006 |
1,770 |
-43.1 % |
2,314 |
3,221 |
-28.1 % |
|
Sales margin, % |
69.5 % |
71.3 % |
65.7 % |
70.9 % |
||
|
EBITDA |
-3,919 |
-2,189 |
-8,476 |
-4,053 |
||
|
EBIT |
-4,026 |
-2,281 |
-8,686 |
-4,202 |
||
|
Profit / loss for the period |
-3,855 |
-2,730 |
-9,483 |
-4,614 |
||
|
R&D expenditure, % of net sales |
109.8 % |
53.5 % |
85.8 % |
48.0 % |
||
|
Equity ratio, % |
84.3 % |
84.9 % |
84.3 % |
84.9 % |
||
|
Cash and cash equivalents |
4,126 |
6,289 |
-34.4 % |
4,126 |
6,289 |
-34.4 % |
|
Earnings per share (undiluted) |
-0.13 |
-0.12 |
-0.31 |
-0.20 |
||
|
Earnings per share (diluted) |
-0.11 |
-0.10 |
-0.28 |
-0.17 |
||
|
Number of shares at the end of the |
30,788,092 |
23,336,858 |
30,788,092 |
23,336,858 |
||